Kiran Mazumdar Shaw

Feb 09, 2016 at 18:22 | Source: PTI
She said to dominate in the field such as biotechnology and information technology what is paramount is human capital, which will actually shape India's science and technology prowess in the world.
Feb 08, 2016 at 07:54 | Source: PTI
Recently, the Central Board of Excise and Customs (CBEC) had issued a notification withdrawing exemption of levy of basic customs duty on as many as 74 drugs.
Feb 05, 2016 at 20:55 | Source: CNBC-TV18
Kiran Mazumdar Shaw, CMD, Biocon, calls this to be an irrational commentary from the governments side, as it will only the end-userthe patientwho will have to pay the increased cost.
Feb 05, 2016 at 10:30 | Source: CNBC-TV18
The US governments decision to not allow overseas pharmaceutical companies to import active pharmaceutical ingredient (API) applies to only one particular anti retroviral drug and is not a blanket ban, Biocon CMD Kiran Mazumdar-Shaw said.
Feb 03, 2016 at 17:09 | Source: CNBC-TV18
From the sidelines of the Karnataka Investment Summit 2016, Gautam Adani, Chairman, Adani Group, told CNBC-TV18: "We have signed the Memorandum of Understanding (MoU) with the state government to expand the existing 1,200 megawatt capacity to additionally 1,600 megawatt capacity in Udipi."
Jan 22, 2016 at 10:01 | Source: Moneycontrol.com
Biocon's subsidiary Syngene International reported a profit of Rs 59 crore in October-December quarter, a growth of 31 percent compared to Rs 45 crore in year-ago period. Revenue in same period increased 23 percent to Rs 281 crore from Rs 229 crore.
Jan 12, 2016 at 08:19 | Source: PTI
Among the industry leaders who have confirmed their attendance to the investor meet include Ratan Tata, Anil Ambani, Anand Mahindra, Sajjan Jindal, Narayana Murthy, Kiran Mazumdar-Shaw, Devi Prasad Shetty, Kris Gopalkrishnan, Gautam Adani, Kumar Mangalam Birla, they said after a high-level committee meeting on the event.
Jan 04, 2016 at 14:27 | Source: PTI
In his new role Hunt would be responsible for strengthening Syngene's relations with its existing global customers as well as forging new relationships, the company said.
Dec 18, 2015 at 17:47 | Source: Moneycontrol.com
Effective approach of capital deployment: NHL uses asset right" approach for expansion of their hospitals. It operates through a combination of models such as a) own and operate, b) revenue sharing, c) lease/rental basis, and d) managed hospitals.
Dec 18, 2015 at 17:41 | Source: Moneycontrol.com
Narayana Hrudayalaya is bringing the issue at price band of Rs 245-250 per share which will convert into P/E multiple of more than 200 on post issue annualized H1FY16 eps of Rs 1.22/ share.
Messages on Kiran Mazumdar Shaw »

stocktin

Platinum Member

64 Followers

Biocon  

which involves big bucks like the 2g,3g, coal etc.In the similar context industrialists like KMS are flower pots they r the face of Indian industry after all you cant showcase an ex custom house clearing agent like Gautam Adani to the world as the face of Indian Industry for that you need Kiran Mazumdar

6.31 PM Jun 9th 2014

Web Messenger

Platinum Member

334596 Followers

News Now  

Source:VC Circle - The company expects its small molecule API and ANDA business to be lead revenue generator followed by research services, biosimilars and branded formulations. Biocon Ltd is India's largest biotechnology company founded by Kiran Mazumdar-Shaw in ...

2.34 PM May 7th 2014

sanecounsel

Platinum Member

134 Followers

Biocon  

BANGALORE: Kiran Mazumdar-Shaw on Friday for the very first time used the words `succession planning`, after having built Biocon into a Rs 3,000-crore global biopharmaceutical enterprise and making it the poster child of India`s biotech prowess in a span of over three decades. The board of Biocon

11.32 AM Apr 27th 2014

stocktin

Platinum Member

64 Followers

Biocon  

ramanujam11 : Great post & the comparision with Apple .however , I am a little queasy about your first point regarding the ipo ,statin company & the hype.Who benefited from the hype created at the time of ipo?? And if this is true then everything that Biocon and Kiran Mazumdar Shaw stand for can

11.29 AM Mar 15th 2014

Web Messenger

Platinum Member

334596 Followers

News Now  

Source:The Hindu BusinessLine - Indian Institute of Management-Bangalore (IIM-B) has appointed Kiran Mazumdar-Shaw as the Chairperson of its board of governors. At the meeting of the board of governors on February 11, the Chairperson, Mukesh D. Ambani, expressed his decision to step down, IIM

4.35 PM Feb 19th 2014

srikanth031
086

Gold Member

183 Followers

Biocon  

Kiran Mazumdar-Shaw, chairman and managing director of Indian biopharmaceutical company Biocon Ltd., will receive the 2014 Othmer Gold Medal at the Chemical Heritage Foundation’s 13th annual Heritage Day celebration May 15. CHF president and CEO Carsten Reinhardt said in a statement that Mazumdar

2.16 PM Jan 31st 2014

Web Messenger

Platinum Member

334596 Followers

Biocon  

Source:Economic Times - MUMBAI: Biocon has justified the Rs 19,500-57,500 pricing for its new breast cancer drug Canmab , with the company`s chairman and managing director Kiran Mazumdar-Shaw saying that the first biosimilar version of Swiss drug maker Roche`s offering has expanded the market.

12.04 PM Jan 25th 2014

Firstpost

Platinum Member

1117 Followers

Economy  

Source:FirstPost - Even though several corporate India executives have recently joined the Aam Aadmi Party while others like Bicon`s Kiran Mazumdar shaw have praised the party for itsanti-corruption stand and, the party` s populist measures are worrying investors on Dalal Street.At the heart

1.15 PM Jan 6th 2014

Web Messenger

Platinum Member

334596 Followers

Biocon  

Source:The Hindu BusinessLine - Rakesh Bamzai, President-Marketing, Biocon Ltd, is leaving the company to take up leadership role elsewhere. He has been associated with Biocon for 19 years.Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon, said that Rakesh has decided to take up

7.08 PM Jan 2nd 2014

Web Messenger

Platinum Member

334596 Followers

Biocon  

Source:The Hindu BusinessLine - Rakesh Bamzai, President-Marketing, Biocon Ltd, is leaving the company to take up leadership role elsewhere. He has been associated with Biocon for 19 years.Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon, said that Rakesh has decided to take up

1.04 PM Jan 2nd 2014

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.